Gottlieb Calls On Congress To Act On US Biosimilars Uptake

Calls to give up on biosimilars in the US are premature, former FDA commissioner Scott Gottlieb insists. Rather, he says, Congress should act to promote uptake and greater competition in the biologics arena.